This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Russian drug from coronavirus ready to purchase in 50 countries
The Russian Direct Investment Fund (RDIF) and the ChemRar Group almost doubled the production of the Russian drug Avonavir coronavirus. Now the drug is being delivered to the regions of the country, but 50 countries are also interested in importing.
According to the RDIF press service, initially it was planned to launch the release of about 60 thousand courses of therapy for coronavirus in June, but production was increased to 100 thousand courses only in the first month. The same production volume is planned for July.
The drug was delivered to 35 regions of Russia and Belarus. Also, the batch will be sent to Kazakhstan. Negotiations are underway on supplies to Latin America, the CIS and the Middle East. In order to expand the export deliveries of Avifavir and meet the demand in the regions, the joint company RDIF and ChemRar will triple the output - up to 300 thousand courses per month.
The drug received registration On May 29, already on June 3, it was included in the last, seventh edition of the guidelines for the treatment of coronavirus. According to Kirill Dmitriev, RDIF CEO, Avifavir is one of the world's most effective drugs against coronavirus today. Russians get it for freefirst batches already sent to the country's hospitals.